Richard W. Paul & Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5K | Buy |
486
+4
| +0.8% | +$193 | 0.01% | 212 |
|
|
2025
Q1 | $26.7K | Sell |
482
-60
| -11% | -$3.33K | 0.01% | 204 |
|
|
2024
Q4 | $26.1K | Buy |
542
+2
| +0.4% | +$96 | 0.01% | 233 |
|
|
2024
Q3 | $31.1K | Buy |
540
+1
| +0.2% | +$58 | 0.01% | 232 |
|
|
2024
Q2 | $26.2K | Buy |
539
+117
| +28% | +$5.68K | 0.01% | 234 |
|
|
2024
Q1 | $20.5K | Buy |
422
+105
| +33% | +$5.1K | 0.01% | 263 |
|
|
2023
Q4 | $15.8K | Sell |
317
-111
| -26% | -$5.52K | 0.01% | 272 |
|
|
2023
Q3 | $23K | Sell |
428
-21
| -5% | -$1.13K | 0.01% | 239 |
|
|
2023
Q2 | $24.2K | Buy |
449
+65
| +17% | +$3.5K | 0.01% | 256 |
|
|
2023
Q1 | $20.9K | Buy |
384
+261
| +212% | +$14.2K | 0.01% | 264 |
|
|
2022
Q4 | $5.96K | Buy |
+123
| New | +$5.96K | ﹤0.01% | 360 |
|